Illumina Appoints Ankur Dhingra As Chief Financial Officer and Jakob Wedel As Chief Strategy and Corporate Development Officer

Apr 09, 2024•over 1 year ago

Position

Chief Strategy And Corporate Development Officer

Company

Illumina

Jakob Wedel

Description

Illumina announces the appointment of Ankur Dhingra as Chief Financial Officer, with extensive experience in the life sciences tools, diagnostics, and pharmaceutical industries. Additionally, Jakob Wedel has been named Chief Strategy and Corporate Development Officer, bringing 25 years of strategy leadership roles with global consulting firms.

Company Information

Company

Illumina

About

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube. Investors:Brian Blanchett858.291.6421 IR@illumina.com Media:Dr. Karen Birmingham646.355.2111 pr@illumina.com

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months